Database for melanoma patient data collection
Creation of a Prospective Melanoma Database
Institut Claudius Regaud · NCT02884362
This study is creating a central database to collect information from melanoma patients to help researchers improve treatments and care for the disease.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Institut Claudius Regaud (other) |
| Locations | 1 site (Toulouse) |
| Trial ID | NCT02884362 on ClinicalTrials.gov |
What this trial studies
This project aims to create a structured and centralized database that collects clinical and biological data from patients diagnosed with melanoma at any stage. By facilitating the integration of this data, the initiative seeks to enhance translational research, bridging the gap between basic and clinical research. The database will be accessible to the scientific community, promoting improved patient care and outcomes in melanoma treatment.
Who should consider this trial
Good fit: Ideal candidates for this project are adults over 18 years old with histologically confirmed melanoma of any stage who are affiliated with a social security system in France.
Not a fit: Patients with psychiatric or medical conditions that prevent them from providing informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this database could significantly enhance the understanding and treatment of melanoma, leading to better patient outcomes.
How similar studies have performed: While the approach of creating a centralized database for melanoma data is not novel, it builds on previous successful initiatives aimed at improving melanoma research and patient care.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age \> 18 years * Histologically confirmed melanoma of any stage * Affiliated to a social security system in france * Who signed the informed consent Exclusion Criteria: * Any psychiatric or medical condition that would make the patient unable to give a signed informed consent
Where this trial is running
Toulouse
- Institut claudius regaud IUCT ONCOPOLE — Toulouse, France (RECRUITING)
Study contacts
- Principal investigator: Nicolas MEYER, MD PHD — Institut claudius regaud Toulouse ONCOPOLE
- Study coordinator: Nicolas MEYER, MD PHD
- Email: Meyer.Nicolas@iuct-oncopole.fr
- Phone: 5 31 15 51 61
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Melanoma, melanoma clinical biological database